EQUITY INVESTOR FD INST HOL PORT 2000 SER E DEF ASSET FUNDS
497, 2001-01-16
Previous: VSAT NET INC, 10SB12G, EX-27, 2001-01-16
Next: BLACK HILLS CORP /SD/, 8-K, 2001-01-16

Institutional Holdings Portfolio Series  00E [ 12/20/2000 -  Current Offering ] | cusip:  29471T568
Fund Overview

As of December 29, 2000
Closing NAV:  1.02153 Previous Close:  1.03001 Change: -0.00848 % Change: -0.82329%

The Objective:
The Portfolio seeks capital appreciation by investing for about one year in a selection of common stocks drawn from the Amex Institutional IndexTM, excluding utilities, if any.

The Strategy:
We apply our Multi-Disciplined stock-selection strategy to the Amex Institutional Index, a capitalization-weighted index of the 75 stocks most widely held among professionally managed institutional portfolios with market values in excess of $100 million. While there can be no guarantee of results, the strategy is intended to produce a balanced portfolio of attractive large-cap stocks.

Offered By:
This portfolio is offered by Merrill Lynch (IHP00E), Morgan Stanley Dean Witter (IHP00E); Special Dealer - PaineWebber (IHP00E).



Portfolio Holdings
Dividend information for the securities listed below is available in the prospectus for this Fund.
The offering, redemption and repurchase prices for the Fund take into account expenses and sales charges.
Therefore, you will not be able to calculate these prices (or related performance information)
with the security prices and weightings listed below.


As of Friday, December 29, 2000
SecuritySymbolPrice% of Portfolio
Medtronic, Inc.MDT60.385.40
Eli Lilly and CompanyLLY93.065.20
Freddie MacFRE68.885.20
American Home Products CorporationAHP63.55 5.15
Wells Fargo CompanyWFC 55.695.14
Tyco International LimitedTYC55.505.12
Pharmacia CorporationPHA61.00 5.12
Enron CorporationENE 83.135.11
Fannie MaeFNM 86.755.09
Bank of New York Co. Inc.BK55.195.09
Minnesota Mining & Manufacturing CompanyMMM120.505.05
Philip Morris Companies, Inc.MO44.005.04
Merck & Company, Inc. MRK93.634.97
Schlumberger LimitedSLB79.944.92
PepsiCo, Inc.PEP49.5 64.85
The Boeing Company BA66.004.80
Schering-Plough CorporationSGP56.754.76
Pfizer, Inc.PFE46.004.76
Abbott LaboratoriesABT48.444.74
Oracle CorporationORCL29.064.47



Selection Methodology:

Using the Amex Institutional Index (excluding utilities) as our universe of stocks, we selected stocks for the Portfolio by applying a combination of fundamental and technical screening methodologies with an emphasis on momentum, based on the following criteria:

  • Price Momentum
  • Recovery
  • Price/Earnings Ratio
  • Dividend Yield

    We then chose the top-ranked issues from each category and combined them into a single portfolio. The resulting collection of quality, large-cap stocks may benefit from the balance of fundamental and technical methodologies built into the selection screens.




  • Past Performance of Prior Series
    Performance From Inception Through September 30, 2000
    Including Annual Rollovers
    Most Recently Completed Portfolio
    Series Inception Date Cumulative Total Return Annualized Return Offer to End Date Annualized Return
    Series B15/4/9938.88%26.21%5/4/99 - 6/6/0043.67%
    Series D29/3/9914.29% 13.21% --- ---
    Series 99C 12/15/994.39% --- --- ---
    Series A3/1/00-2.10% --- --- ---
    1. This Portfolio was originally Series 99A and rolled into 2000 Series B on May 10, 2000.
    2. This Portfolio was originally Series 99B and rolled into 2000 Series D on September 14, 2000.


    Past performance is no guarantee of future results. Unit prices and investment returns fluctuate with changes in market conditions. Your investment may be worth more or less than your original cost when you redeem. Returns represent changes in unit price plus reinvestment of any distributions, divided by the initial offer price, and reflect deduction of maximum applicable sales charges and expenses. "From Inception" returns differ from "Most Recently Completed Portfolio" returns because the former figures reflect different performance periods and a reduced sales charge on annual rollovers.

    Contact your Financial Professional for a free prospectus (or download one from this site) containing more complete information on any Defined Asset Fund, including sales charges, expenses and risks. Please read it carefully before you invest or send money.




    Fees & Expenses

    Defining Your Costs
    You will pay an initial sales charge of about 1% the first time you buy. In addition, you'll pay a deferred sales charge of $15.00 per 1,000 units.
    Unitholder Fees
    Maximum as a %
    of the Amount Invested

    Creation and Development Fee
    (0.250% of net assets)
    0.30%
    Sales Charges
    2.50%

    Total Maximum Sales Charges
    (including creation and development fee)
    2.80%

    If you sell your units before termination, any remaining balance of your deferred sales charge will be deducted, along with the estimated costs of selling Portfolio securities, from the proceeds you receive. If you roll over to a successor Portfolio, if available, the initial sales charge on that Portfolio will be waived. You will only pay the deferred sales charge.

    Portfolio Expenses
    Amount per 1,000 Units

    Estimated Operating Expenses
    (0.187% of net assets)
    $1.85
     
    Estimated Organization Costs
    $1.30


    Volume Purchase Discounts
    For larger purchases, the initial sales charge (but not the Creation and Development Fee) is reduced to put more of your investment dollars to work for you. The deferred sales charge will not change.

    If You
    Invest:
    Your Initial Sales Charge
    (as a % of your investment) Will Be:*

    Less than $50,000 1.00%
    $50,000 to $99,999 0.75%
    $100,000 to $249,000 0.25%
    $250,000 to $999,999 0.00%

    If you invest $1,000,000 or more, you will not pay any initial sales charge, and will receive additional units, effectively reducing your deferred sales charge to 0.75% of your investment.

    *These percentages are based on a unit price of $1,000 per 1,000 units and will vary as the unit price changes.



    Is this Fund appropriate for you?

    Yes, if you seek capital appreciation. You may benefit from a professionally selected and supervised portfolio based on a multi-disciplined strategy applied to the Amex Institutional Index.

    Risk Considerations

    Please keep in mind the following factors when considering this investment. Your financial professional will be happy to answer any questions you may have.

    Each screen involves an element of momentum, which may result in underperformance in declining markets.

    This Portfolio is designed for investors who can assume the risks associated with equity investments, and generally is not appropriate for investors seeking capital preservation or current income.

    The value of your investment will fluctuate with the prices of the underlying stocks. Stock prices can be volatile.

    There can be no assurance that this Portfolio will meet its objective, or that it will outperform the Index.

    This Portfolio may be considered to be concentrated in healthcare stocks which may involve special risks such as significant research costs and rapid obsolescence.

    The Portfolio does not reflect research opinions or any buy or sell recommendations of any of the Sponsors.

    For more information on risk considerations, see the prospectus for this Fund.




    Distributions and Taxes

      Distribution Frequency (if any)
        Two (2) per year.
      Reinvestment Options
        By selecting the reinvestment option, you may choose to have your distributions used to purchase additional units of the fund (reinvestment). As such, your investment will increase each distribution period. Because distributions are based in part on the size of your investment, these payments may increase proportionately. However, distributions are not assured and the value of your investment may increase or decrease.
      Tax Reporting
       

    When seeking capital appreciation, managing tax liability on capital gains can be important to your overall return. By holding this Fund for more than one year, individuals may be eligible for favorable federal tax rates on net long-term capital gains (currently no more than 20%).

    Generally, dividends and any net capital gains will be subject to tax each year, whether or not reinvested. However, on rollovers to future Portfolios, if available, certain investors may defer recognition of gains and losses on stocks that are transferred to the new Portfolio. Please consult your tax advisor concerning state and local taxation.

    Your taxable income may include some foreign withholding taxes. However, subject to limitations, you may be able to credit these taxes against your U.S. Federal Income Taxes.




    The Bank of New York
    Unit Investment Trust Department
    PO Box 974
    Wall Street Division
    New York, New York 10268-0974
    1-800-221-7771

    Defined Asset Funds® are established as Unit Investment Trusts. By definition, a trust account requires a trustee. The trustee holds the trust securities, ensuring their safekeeping until the trust is terminated. The trustee is also responsible for recordkeeping, for collecting any interest or dividend income and principal payments, and for distributing this money to investors.




                       L I N K S  T O  S P O N S O R  W E B  S I T E S                   
    Merrill Lynch   |   Salomon Smith Barney   |   PaineWebber   |   Morgan Stanley Dean Witter

    The performance, fee and expense information included on this site will differ for Defined Asset Funds held in certain eligible accounts offered by the Sponsors. Please contact your financial professional for more information on these types of accounts.

    "Amex" and "Amex Institutional Index" are trademarks of the American Stock Exchange, LLC, a subsidiary of the NASD, and have been licensed for use by Defined Asset Funds. The Portfolio is not sponsored, managed, sold or promoted by the American Stock Exchange. The American Stock Exchange does not guarantee the accuracy or completeness of the Amex Institutional Index.

    Not all strategies are appropriate at all times. The opinions expressed in this site do not constitute investment advice. Independent advice should be sought in cases of doubt.

    For more complete information about any of the funds, including their risks, fees, sales charges and other expenses, please download a prospectus from this site, or obtain one free of charge from your financial professional. The prospectus should be read carefully before you invest or send money.

    Not all funds are registered for sale in all states. Ask your financial representative about the availability of specific funds in your state. In addition, the funds described here are not available to investors outside the US. Defined Asset Funds are sold by prospectus only. The prospectus is not an offer to sell or a solicitation of an offer to buy units in the funds, nor shall any such units be offered or sold to any person in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.

    As a unitholder, you may receive taxable dividends and capital gains. Taxes on these distributions can affect the returns you realize from your investment. The Sponsors do not offer tax advice except to suggest that you consider the impact of taxes and that you may want to consult with your tax advisor before making any investment.

    Funds holding international securities can involve different risks than US investments. The risks include political and economic instability, changing currency exchange rates, foreign taxes and differences in financial accounting standards.

    Use of this site signifies your acceptance of our
    Terms and Conditions and Privacy Policy

    The information on this Internet site is directed at, and is intended for distribution to, and use by, persons in the United States only.
    

    © 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission